DPP4 and myalgic encephalomeyelitis/chronic fatigue syndrome: ROC curve analyses and AUC, shown in Table 2 and Figures 2, 3, and 4 indicated that all three measures of CD26 have potential as biomarkers for CFS (see COCs in Tables S2, S3, and S4).